Managing Infliximab Reinduction After temporary Discontinuation of Drug
Brief description of study
The purpose of this study is to determine what is the best schedule for restarting infliximab (also known as Remicade) in patients with inflammatory bowel disease (IBD), specifically ulcerative colitis (UC) and Crohn’s disease (CD), who have undergone infliximab infusions before. We will not be involved in determining how you restart infliximab, but will track what happens with your IBD control once the medication is restarted. We will assess your clinical response to restarting treatment by collecting information (surveys, medical chart information) and samples (blood and stool).
Clinical Study Identifier: s15-01180
ClinicalTrials.gov Identifier: NCT02771457
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
